gilteritinib
astellas pharmaceuticals
['dial', 'leusm']
#eha22 #leusm martinelli: 62.5% on admiral received gilt maint after allohct. no relapses in those patients. transaminases, myalgias and pericardial effusions are differentiating aes with gilt. 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)